|
FAM13B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.34969999013401E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.520000E-01 |
| Stage1-vs-Stage3 |
1.392560E-01 |
| Stage1-vs-Stage4 |
1.366380E-04 |
| Stage2-vs-Stage3 |
1.018220E-01 |
| Stage2-vs-Stage4 |
2.015600E-03 |
| Stage3-vs-Stage4 |
2.990200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.24019999825364E-08 |
| Normal-vs-Asian |
2.22689644502339E-11 |
| Caucasian-vs-AfricanAmerican |
8.110400E-01 |
| Caucasian-vs-Asian |
5.495400E-01 |
| AfricanAmerican-vs-Asian |
5.545600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.110200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.68050000000286E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.947200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.706200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.021000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.207200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.850200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.899200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.604410E-02 |
| Classical-VS-Follicular |
9.952100E-02 |
| Classical-VS-Other |
1.968160E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.650400E-01 |
| Tall-VS-Other |
9.433800E-01 |
| Tall-VS-Normal |
1.29896093881143E-14 |
| Follicular-VS-Other |
4.864600E-01 |
| Follicular-VS-Normal |
1.62547753035369E-12 |
| Other-VS-Normal |
4.14579999999942E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.202300E-02 |
|
|
